SCHEMBL15427271

SCHEMBL15427271

CCS(=O)(=O)c1ccccc1-c1nc2cc(C#N)cnc2n1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.39
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
GLA P06280 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
HPGD P15428 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
IRAK4 Q9NWZ3 6/20 0.35
ATR Q13535 1/20 0.35
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15412773 0.85 BRD4 (0.40) KMT2AALDH1A1CYP1A2ATRALOX5AP
SCHEMBL15412733 0.83 AKT1 (0.39) MEN1KMT2AALDH1A1SMN1; SMN2HSD17B10
SCHEMBL15412419 0.83 ALOX5AP (0.36) ALDH1A1ATRALOX5APFEN1NR1I2
SCHEMBL9952255 0.83 ALOX5AP (0.36) MEN1KMT2AATRALOX5APFEN1
SCHEMBL15412482 0.82 USP30 (0.40) USP2ALDH1A1CYP1A2GLACYP3A4
SCHEMBL10280731 0.82 HSD11B1 (0.38) SMN1; SMN2ATRALOX5APFEN1NR1I2
SCHEMBL15426433 0.81 ALOX5AP (0.35) ATRALOX5APFEN1NR1I2HSD11B1
SCHEMBL15412012 0.80 POLB (0.46) MEN1KMT2AALDH1A1ALOX5APFEN1
SCHEMBL15412570 0.80 ALOX5AP (0.39) ATRALOX5APFEN1NR1I2HSD11B1
SCHEMBL15412638 0.80 ALOX5AP (0.42) ATRALOX5APFEN1USP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278983-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-08 US disclosed
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-11 US disclosed
US-8853238-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-10-07 US disclosed
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF NR4A1, NR2C2, NR0B1 PTGER4 2725/4885MEN1 767/4885KMT2A 700/4885
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL NR4A1, NR2C2, NR0B1 PTGER4 2766/4885MEN1 795/4885KMT2A 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.